EU Consultations on Sputnik V Vaccine Authorisation Set for 19 January, RDIF CEO Says

Jan 13, 2021 | EARNINGS

MOSCOW (Sputnik) – The European Union is set to conduct a scientific review of Russia’s Sputnik V vaccine against COVID-19 on 19 January, which could be the first step toward gaining emergency use approval in the bloc, Kirill Dmitriev, the CEO of the Russian Direct Investment Fund (RDIF), told Sputnik on Wednesday.

Read More

Pin It on Pinterest